Kirkland Guides Baxter's $4B Buy Of Dialysis Co. Gambro

Law360, New York (December 4, 2012, 12:42 PM EST) -- Health care company Baxter International Inc. will pick up Swedish dialysis product maker Gambro AB for about $4 billion to flesh out its existing kidney care portfolio as the global market for related treatments grows, Baxter said Tuesday.

Illinois-based Baxter did not give a financing breakdown, but said it would cover the purchase price with a mix of on-hand cash generated through overseas operations and new debt. Subject to regulatory approval, Baxter expects to officially acquire privately held Gambro in the first half of next year....
To view the full article, register now.